Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients-Reference-Cited by-同舟云学术

Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients

Published:2022-08 Issue:8 Volume:22 Page:589-595
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Halahleh Khalid^ORCID,Al Sawajneh Suhaib,Saleh Yacob,Shahin Omar,Abufara Alaa,Ma'koseh Mohamad,Abdel-Razeq Rashid,Barakat Fareed,Abdelkhaleq Hadeel,Al-Hassan Nadira,Atiyyat Reem,Al-Faker Noor,Omari Zaid,Ghatasheh Hamza,Jaradat Imad,Muradi Isa,Iyad Sultan,Bazarbachi Ali

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Teras;CA Cancer J Clin,2016

2. The epidemiology of lymphoma in Jordan: a nationwide population study of 4189 cases according to World Health Organization classification system;Aladily;Hematol Oncol Stem Cell Ther,2021

3. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD;Ganellos;N Engl J Med,1992

4. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned;Viviani;N Engl J Med,2011

5. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges;Expert Review of Hematology;2024-06-27

2. Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?;Vaccines;2023-12-12

3. Effectiveness and Safety of Pembrolizumab in Recurrent and Relapsed Classic Hodgkin Lymphoma: A Systematic Review ;Cureus;2023-09-26

5. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma;Journal of Clinical Medicine;2022-11-06